• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Julie R. Korenberg, MD, PhD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English, French, German, Spanish

Dr. Korenberg, PhD, MD, received her PhD in Genetics followed by her post-doctoral fellowship in electron microscopy of human chromosomes (University of Wisconsin) and then her medical degree from the University of Miami School of Medicine Ph.D. - M.D. Program. She went on to complete her Pediatric residency at Children's Hospital Medical Center (CHMC) and Harvard University Medical School (HMS). Dr. Korenberg’s Fellowship as a Cystic Fibrosis Fellow (Clinical Pulmonology and Molecular Biology) was completed at HMS, Ina Sue Perlmutter Cystic Fibrosis Research Center and CHMC in Boston, MA. During this time, she also served as a physician in Emergency Medicine at a major trauma center. Her fellowship and boards in Medical Genetics followed at the University of California, San Francisco’s Moffitt Hospital. At the heart of Dr. Korenberg’s clinical and research lies her understanding of lifespan genetic defects, particularly those involving brain, nervous system and heart. As faculty in the Department of Pediatrics and Human Genetics at the University of California at Los Angeles, CSHS, she rose rapidly with multiple accelerations from Assistant Professor to Professor VIII and was bestowed with numerous honors for her pioneering work in Pediatrics, Medical Genetics, Human Genome, Molecular Genetic diagnosis for genetic syndromes and cancers, mouse models of human disease, and as a founder and founding member of the Department of Human Genetics, UCLA and at Cedars-Sinai Health System (CSHS). Dr. Korenberg also established the Neurofibromatosis Clinic and Programs for Down Syndrome and Williams Syndrome at CSHS. An international leader in neurodevelopmental disorders, DS “Protocols to establish genotype/phenotype correlations in Down syndrome,” the classic standard for diagnosis of Down Syndrome through the present work on clinical and fundamental work on genetic wiring of brain functions. National advisory boards in Clinical and Research, NIH service, study sections for NICHD, NIMH, Mental Retardation, National Institute of Child Health and Human Development (NICHD), Down syndrome Therapeutic Consortium, Williams syndrome diagnosis, treatment, genes for behavior. Specialties include lifespan work on Down syndrome, Williams syndrome, chromosomal abnormalities and more recently disorders of social behavior including autism and other psychiatric genetic conditions. Dr. Korenberg is certified by the American Boards of Pediatrics, Medical Genetics and Molecular Genetics and specializes in diagnosis and treatment of individuals with rare forms of conditions in these specialities, using a wholistic approach.


Dr. Korenberg currently is USTAR Professor of Pediatrics, Director of the USTAR Cluster, Circuits of the Brain, Director of the Center for Integrated Neuroscience and Human Behavior and founder and director of the new Down Syndrome Therapeutic Consortium (DSTC) and of the emerging Williams Syndrome Program at the University of Utah. Dr. Korenberg is Faculty member in the Neuroscience Interdepartmental Graduate Program at the University of Utah. She holds numerous patents and leads the the National Institute of Child Health and Human Development (NICHD)-funded DSTC, has been awarded continuous funding for more than 25 years by institutions including the Department of Energy, the Alzheimer’s Foundation, the American Heart Association, the McDonnell Foundation and the State of Utah.

Clinical Locations

Eccles Primary Children’s Outpatient Services Building

81 N Mario Capecchi Drive
Salt Lake City, UT  84113
Map

Specialties

  • Pediatric Genetics

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Neurology - Adjunct Professor
Academic Divisions Pediatric Genetics
Board Certification American Board of Medical Genetics (Clinical Genetics)
American Board of Medical Genetics (Clinical Molecular Genetics)
American Board of Pediatrics (Pediatrics)

Dr. Korenberg, PhD, MD, received her PhD in Genetics followed by her post-doctoral fellowship in electron microscopy of human chromosomes (University of Wisconsin) and then her medical degree from the University of Miami School of Medicine Ph.D. - M.D. Program. She went on to complete her Pediatric residency at Children's Hospital Medical Center (CHMC) and Harvard University Medical School (HMS). Dr. Korenberg’s Fellowship as a Cystic Fibrosis Fellow (Clinical Pulmonology and Molecular Biology) was completed at HMS, Ina Sue Perlmutter Cystic Fibrosis Research Center and CHMC in Boston, MA. During this time, she also served as a physician in Emergency Medicine at a major trauma center. Her fellowship and boards in Medical Genetics followed at the University of California, San Francisco’s Moffitt Hospital. At the heart of Dr. Korenberg’s clinical and research lies her understanding of lifespan genetic defects, particularly those involving brain, nervous system and heart. As faculty in the Department of Pediatrics and Human Genetics at the University of California at Los Angeles, CSHS, she rose rapidly with multiple accelerations from Assistant Professor to Professor VIII and was bestowed with numerous honors for her pioneering work in Pediatrics, Medical Genetics, Human Genome, Molecular Genetic diagnosis for genetic syndromes and cancers, mouse models of human disease, and as a founder and founding member of the Department of Human Genetics, UCLA and at Cedars-Sinai Health System (CSHS). Dr. Korenberg also established the Neurofibromatosis Clinic and Programs for Down Syndrome and Williams Syndrome at CSHS. An international leader in neurodevelopmental disorders, DS “Protocols to establish genotype/phenotype correlations in Down syndrome,” the classic standard for diagnosis of Down Syndrome through the present work on clinical and fundamental work on genetic wiring of brain functions. National advisory boards in Clinical and Research, NIH service, study sections for NICHD, NIMH, Mental Retardation, National Institute of Child Health and Human Development (NICHD), Down syndrome Therapeutic Consortium, Williams syndrome diagnosis, treatment, genes for behavior. Specialties include lifespan work on Down syndrome, Williams syndrome, chromosomal abnormalities and more recently disorders of social behavior including autism and other psychiatric genetic conditions. Dr. Korenberg is certified by the American Boards of Pediatrics, Medical Genetics and Molecular Genetics and specializes in diagnosis and treatment of individuals with rare forms of conditions in these specialities, using a wholistic approach.


Dr. Korenberg currently is USTAR Professor of Pediatrics, Director of the USTAR Cluster, Circuits of the Brain, Director of the Center for Integrated Neuroscience and Human Behavior and founder and director of the new Down Syndrome Therapeutic Consortium (DSTC) and of the emerging Williams Syndrome Program at the University of Utah. Dr. Korenberg is Faculty member in the Neuroscience Interdepartmental Graduate Program at the University of Utah. She holds numerous patents and leads the the National Institute of Child Health and Human Development (NICHD)-funded DSTC, has been awarded continuous funding for more than 25 years by institutions including the Department of Energy, the Alzheimer’s Foundation, the American Heart Association, the McDonnell Foundation and the State of Utah.

Academic Locations

Board Certification and Academic Information

Academic Departments Pediatrics - Professor
Neurology - Adjunct Professor
Academic Divisions Pediatric Genetics
Board Certification American Board of Medical Genetics (Clinical Genetics)
American Board of Medical Genetics (Clinical Molecular Genetics)
American Board of Pediatrics (Pediatrics)

Education History

Postdoctoral Fellowship University of California - San Francisco
Medical Genetics – Pediatrics
Postdoctoral Fellow, 1986
Fellowship Harvard Medical School, Ina Sue Perlmutter Cystic Fibrosis Research Center
Cystic Fibrosis Fellow (Molecular Biology)
Fellow, 1983
Residency Children's Hospital Medical Center, Harvard University
Pediatrics
Resident, 1982
Internship Children's Hospital Medical Center, Harvard University
Pediatrics
Intern, 1980
Professional Medical University of Miami School of Medicine
Ph.D. - M.D. Program
M.D., Ph.D., 1979
Postdoctoral Training University of Wisconsin
Asst. Scientist, Departments of Zoology and Genetics
Postdoctoral Training, 1977
Doctoral Training University of Wisconsin
Medical Genetics
Ph.D., 1976
Graduate Training University of Wisconsin
Medical Genetics
M.S., 1976
Undergraduate McGill University
Genetics and Humanities
B.Sc., 1968
Other Training Woods Hole Marine Biological Laboratory
Embryology Course and Research
,

Selected Publications - Journal Articles

Journal Article

  1. Dai L, Weiss RB, Dunn DM, Ramirez A, Paul S, Korenberg JR (2020). Core transcriptional networks in Williams syndrome: IGF1-PI3K-AKT-mTOR, MAPK and actin signaling at the synapse echo autism. Hum Mol Genet, 30(6), 411-429.
  2. Chen XN, Korenberg JR (2002). BAC resource for molecular cytogenetics. Methods Mol Biol, 204, 391-403.
  3. Weier H, Munn S, Lersch RA, Hsieh H, Smida J, Chen X, Korenberg JR, Pedersen RA, Fung J (2001). Towards a full karyotype screening of interphase cells: 'FISH and chip' technology. Mol Cell Endocrinol, 183 Suppl 1, S41-5.
  4. Ianakiev P, Kilpatrick MW, Dealy C, Kosher R, Korenberg JR, Chen XN, Tsipouras P (1999). A novel human gene encoding an F-box/WD40 containing protein maps in the SHFM3 critical region on 10q24. Biochem Biophys Res Commun, 261(1), 64-70.
  5. Korenberg JR, Chen XN, Devon KL, Noya D, Oster-Granite ML, Birren BW (1999). Mouse molecular cytogenetic resource: 157 BACs link the chromosomal and genetic maps. Genome Res, 9(5), 514-23.
  6. Zhang X, Yang H, Corydon MJ, Zhang X, Pedersen S, Korenberg JR, Chen XN, Laporte J, Gregersen N, Niebuhr E, Liu G, Bolund L (1999). Localization of a human nucleoporin 155 gene (NUP155) to the 5p13 region and cloning of its cDNA. Genomics, 57(1), 144-51.
  7. Haldi ML, Strickland C, Lim P, VanBerkel V, Chen X, Noya D, Korenberg JR, Husain Z, Miller J, Lander ES (1996). A comprehensive large-insert yeast artificial chromosome library for physical mapping of the mouse genome. Mamm Genome, 7(10), 767-9.
  8. Korenberg JR, Chen XN, Tran H, Argraves WS (1995). Localization of the human gene for fibulin-1 (FBLN1) to chromosome band 22q13.3. Cytogenet Cell Genet, 68(3-4), 192-3.
  9. Malo MS, Srivastava K, Andresen JM, Chen XN, Korenberg JR, Ingram VM (1994). Targeted gene walking by low stringency polymerase chain reaction: assignment of a putative human brain sodium channel gene (SCN3A) to chromosome 2q24-31. Proc Natl Acad Sci U S A, 91(8), 2975-9.
  10. Wilson L, Curtis A, Korenberg JR, Schipper RD, Allan L, Chenevix-Trench G, Stephenson A, Goodship J, Burn J (1993). A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet, 53(6), 1262-8.
  11. Sainz J, Rasmussen M, Nechiporuk A, Vissing H, Cheng X, Korenberg JR, Pulst SM (1993). Dinucleotide repeat polymorphism at the D22S351 locus. Hum Mol Genet, 2(10), 1749.

Patent

  1. Korenberg JR, Chen X (2006). Isolated SH3 genes associates with myeloproliferative disorders and leukemia and uses thereof. U.S. Patent No. 7,070,954. Washington, D.C.:U.S. Patent and Trademark Office.
  2. Korenberg JR, Chen (2006). “Isolated SH3 genes associates with myeloproliferative disorders and leukemia and uses thereof.”. U.S. Patent No. 7,070,954 B1. Washington, D.C.:U.S. Patent and Trademark Office.
  3. Korenberg JR, et al. (2000). "Chromosome 21 Gene Marker, Compositions & Methods Using Same". U.S. Patent No. 6,166,180. Washington, D.C.:U.S. Patent and Trademark Office.
  4. Korenberg JR (2000). "Congenital Heart Disease: Proteins and Products Related Hereto". U.S. Patent No. 6,040,429. Washington, D.C.:U.S. Patent and Trademark Office.

Global Impact

Education History

Undergraduate McGill University
Genetics and Humanities
B.Sc.

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Price Estimate
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

Appointment Scheduling:
801-213-9500

Hospital Operator:
801-581-2121

En Español:
801-646-5914

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2023 University of Utah Health